Blog Exposure – KKR to Acquire PetVet Care Centers

Stock Monitor: Hennessy Advisors Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 29, 2017 / Active-Investors.com has just released a free research report on KKR & Co. L.P. (KKR) (“KKR”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=KKR as the Company’s latest news hit the wire. On December 27, 2017, the Company declared that it has struck an agreement to acquire PetVet Care Centers, LLC (“PetVet”) from Ontario Teachers’ Pension Plan, L Catterton, and other existing shareholders. The financial details of the transaction remain undisclosed. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Hennessy Advisors, Inc. (HNNA), which also belongs to the Financial sector as the Company KKR & Co. Do not miss out and become a member today for free to access this upcoming report at: www.active-investors.com/registration-sg/?symbol=HNNA.

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, KKR & Co. most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=KKR

KKR is making its investment primarily through its Core Investments strategy, representing capital targeting longer-term compounding opportunities.

Partnership Likely to Accelerate KKR’s Track Record of Acquisitive Growth

Max Lin, Member of KKR, stated that PetVet has established itself as a leading veterinary care provider with an unmatched reputation for customer satisfaction and differentiated focus on local communities. Lin added that KKR’s partnership with PetVet and its affiliated veterinarians will accelerate the former’s track record of organic and acquisitive growth.

KKR Acquisition Agreements in 2017

• On December 20, 2017, KKR entered into an agreement with an affiliate of Sun European Partners, LLP to acquire a majority stake in Afriflora. On December 08, 2017, KKR acquired Hyperion, a leading manufacturer of industrial tool components, from Sandvik.

• In August 2017, KKR acquired Covenant Surgical Partners from DFW Capital Partners, Iroquois Capital Group, PineBridge Investments, and other existing shareholders. In the same month, a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc. as a minority investor, acquired PharMerica Corp.

• On July 24, 2017, The Carlyle Group sold its majority control of The Nature’s Bounty Co., a global manufacturer, marketer, and distributor of health and wellness products, to KKR. On the same date, KKR signed an agreement to acquire WebMD Health Corp. in a transaction valued at approximately $2.8 billion.

• On May 08, 2017, KKR, Dunas Capital, and the hotel group Alua Hotels & Resorts entered into an agreement to acquire and manage the Intertur Hotels Group.

• In March 2017, KKR and CDPQ, along with USI employees, announced their joint acquisition of USI Insurance Services, a leading US insurance brokerage and consulting firm. KKR acquired Travelopia from TUI AG in February 2017.

About KKR & Co. L.P.

Founded in 1976, KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, credit, and through its strategic manager partnerships, hedge funds. The Company invests its own capital alongside its partners’ capital and provides financing solutions and investment opportunities through its capital markets business. KKR is headquartered in New York City, New York.

About PetVet Care Centers, LLC

Established in 2012, PetVet provides veterinarian services for veterinary clinics and veterinary practices. Headquartered in Westport, Connecticut, the Company is a leading acquirer and operator of general practice and specialty veterinary hospitals with 125 facilities located across 22 states, and works in partnership with over 600 board certified specialists and general veterinarians.

Stock Performance Snapshot

December 28, 2017 - At Thursday’s closing bell, KKR & Co.’s stock was slightly up 0.28%, ending the trading session at $21.13. Volume traded for the day: 1.95 million shares. Stock performance in the last month – up 7.64%; previous three-month period – up 5.70%; past twelve-month period – up 35.36%; and year-to-date - up 37.30%
After yesterday’s close, KKR & Co.’s market cap was at $17.28 billion. Price to Earnings (P/E) ratio was at 10.63. The stock has a dividend yield of 3.22%. The stock is part of the Financial sector, categorized under the Asset Management industry. This sector was up 0.4% at the end of the session.

Active-Investors:
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE:Active-Investors